+
Site Tour

AV VALVES Summit 2023 Trending Controversies Round 2: Replace, Repair in TR

Tricuspid transcatheter edge-to-edge repair (TEER) has been proven to treat a broad range of patient anatomies, however new options are emerging. What do we know about the different treatment options? Round 2 of the trending controversies session addresses this topic with Laura Sanchis, Maria Isabel Körber and Vlasis Ninios.

FIND OUT MORE ON AV VALVE SUMMIT 2023:

Watch on Demand videos

Related Videos

AV VALVES 2023: MR – Mixed MR

AV VALVES 2023: TR – Multileaflet Valve

AV VALVES 2023: MR – MAC

AV VALVES 2023: Staged, Concomitant

Review the Trends | Tricuspid focus

PCR London Valves 2022 – Treatment of Mitral Valve disease

EuroPCR 2021: Advancing solutions for tricuspid regurgitation patients

EuroPCR 2022: Leading clinical evidence

T-TEER: echo procedural approach

Screening Transmission | Mitral focus

EACTS 2022: SMV repair vs replacement

Transcatheter Mitral Valve implant

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

CONNEXT


HUB
RELATED RESOURCES

EuroEcho 2021: bRIGHT Gap Analysis

PCRLV 2021: Transcatheter mitral valve replacement

TCT 21: EXPAND G4

PCRLV 2022: bRIGHT 1 year

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: MR – Acute Rupture

ESC 2023 Tutorial – TriClip™ | Dr. Coisne

AV VALVES 2023: Replace, Repair in TR

Echo course tricuspid TEER – patient selection

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline